Evaluation of “<i>Caterina assay</i>”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification
Here we describe the first molecular test developed in the early stage of the pandemic to diagnose the first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Sardinian patients in February–March 2020, when diagnostic certified methodology had not yet been adopted by...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2021-03-01
|
| Серія: | Pathogens |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2076-0817/10/3/325 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
